在息患者中停用心脏植入式电子设备:何时以及如何
Tatiana Oliveira1, Nuno Ferreira Monteiro1, Patrícia Cipriano1
1Internal Medicine Unit, Department of Medicine, Cascais Hospital Dr. José de Almeida, Cascais, Portugal.
概括
在生命末期讨论心脏器件停用至关重要. 虽然可植入式心脏转移器除器和左心室辅助设备可能会被停用,但起器和心脏再同步治疗通常不建议停用.
科学领域:
- 心脏病学 心脏病学
- 抚慰性护理是一种缓解性护理.
- 医学伦理 医学伦理
背景情况:
- 心脏植入式电子设备 (CIED) 显著提高了生活质量和生存率.
- 关于CIED停用的讨论对于息治疗和终身护理至关重要.
- 患者的偏好和设备类型会影响停用决定.
研究的目的:
- 审查在息护理机构中关闭各种CIED的考虑因素.
- 澄清在生命结束时关闭可植入心脏转换器除器 (ICD),节律起器,心脏再同步治疗 (CRT) 设备和左心室辅助设备 (LVAD) 的建议.
- 强调预先护理计划对CIED管理的重要性.
主要方法:
- 文献综述和当前关于CIED停用在终身护理中的建议的综合.
- 对不同类型的设备进行临床场景分析和伦理考虑.
- 讨论关闭对患者症状和生活质量的影响.
主要成果:
- 建议在冲击频繁并导致痛苦时关闭植入式心脏转动器除器 (ICD).
- 心脏起器的停用是有争议的,并且通常不会在依赖节奏的患者中进行,因为可能会出现胸肌梗塞症状.
- 不建议停用心脏再同步治疗 (CRT),因为它可能会加剧症状;接受左心室辅助装置 (LVAD) 停用以减轻设备负担.
结论:
- 针对CIED的停用决定必须根据设备类型,患者状况和护理目标进行个性化.
- 提前护理规划至关重要,以确保患者的自主权和关于CIED停用的知情同意.
- 虽然一些CIED在生命终端停用时提供了明显的好处,但其他需要仔细考虑以避免不良结果.
相关概念视频
Heart Failure Drugs: Inotropic Agents
564
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
564
Pulse rhythm
782
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
782
Cardiac Action Potential
1.3K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.3K


